Skip to main content

Table 2 Whole disc vascular density, inside disc vascular density, Peripapillary vascular density, and retinal nerve fiber layer (RNFL) thickness 1 month, and 3 months after pan-retinal photocoagulation (PRP) or intravitreal bevacizumab (IVB) injection. Diff: difference; CI: confidence interval

From: Effect of panretinal photocoagulation versus intravitreal bevacizumab injection on optic disc microcirculation in patients with diabetic retinopathy

Variable

Time

 

Treatment

Diff

95% CI

P†

PRP

(Mean ± SD)

IVB

(Mean ± SD)

Lower

Upper

Whole disc

        
 

Baseline

 

45.5 ± 3.2

46.4 ± 3.4

-0.88

-2.75

0.99

0.357

 

Month 1

 

44 ± 3.3

47.4 ± 2.8

-3.33

-5.09

-1.57

0.002

 

Change 0–1

 

-1.54 ± 3.25

+ 0.99 ± 3.08

-2.45

-4.29

-0.61

0.009

 

P-within‡

 

0.032

0.327

    
 

Month 3

 

44.2 ± 3.2

47.5 ± 3.3

-3.22

-1.27

-5.16

0.001

 

Change 0–3

 

-1.32 ± 2.33

+ 1.15 ± 3.69

-2.63

-0.98

-4.28

0.002

 

P-within‡

 

0.004

0.352

    
 

Change 1–3

 

-0.19 ± 2.41

+ 0.16 ± 2.89

-0.48

-1.85

0.9

0.497

 

P-within‡

 

0.999

0.99

    

Inside disc

        
 

Baseline

 

47.7 ± 6.1

43.1 ± 6.3

4.44

0.81

8.08

0.017

 

Month 1

 

44.7 ± 5.6

45 ± 5.7

-0.5

-3.26

4.23

0.795

 

Change 0–1

 

-2.99 ± 6.33

+ 1.85 ± 6.89

-4.58

-8.41

-0.75

0.019

 

P-within‡

 

0.032

0.485

    
 

Month 3

 

44.7 ± 5.2

44 ± 7.7

1.02

-3.2

5.23

0.636

 

Change 0–3

 

-3.68 ± 5.47

+ 0.89 ± 8.11

-4.68

-8.46

-0.91

0.015

 

P-within‡

 

0.001

0.935

    
 

Change 1–3

 

-1.17 ± 4.59

-0.95 ± 6.68

-1.24

-3.21

0.72

0.215

 

P-within‡

 

0.871

0.865

    

Peripapillary vascular density

        
 

Baseline

 

47.7 ± 3.6

49.3 ± 4.4

-1.67

-0.06

3.95

0.153

 

Month 1

 

45.8 ± 3.9

50.3 ± 3.1

-4.33

-6.38

-2.29

0.001

 

Change 0–1

 

-1.85 ± 3.56

+ 0.95 ± 3.86

-2.95

-4.87

-1.06

0.002

 

P-within‡

 

0.016

0.552

    
 

Month 3

 

45.7 ± 3.8

50.2 ± 3.9

-4.26

-6.63

-1.88

0.001

 

Change 0–3

 

-1.83 ± 3.55

+ 0.9 ± 3.74

-2.74

-4.78

-0.69

0.009

 

P-within‡

 

0.011

0.58

    
 

Change 1–3

 

-0.39 ± 2.93

+ 0.06 ± 3.05

-0.42

-1.97

1.14

0.599

 

P-within‡

 

0.99

0.99

    

RNFL thickness

        
 

Baseline

 

104.6 ± 17.5

112 ± 19.8

-5.15

-18.07

7.77

0.434

 

Month 1

 

114.2 ± 15.6

109.3 ± 19.7

5.84

-6.39

18.06

0.349

 

Change 0–1

 

+ 9.52 ± 7.32

-2.71 ± 5.46

-11.65

-7.5

-15.79

0.001

 

P-within‡

 

0.002

0.58

    
 

Month 3

 

110.7 ± 16.3

107.4 ± 18

5.66

-6.15

17.47

0.348

 

Change 0–3

 

+ 5.05 ± 7.07

-4.62 ± 5.55

+ 9.22

-4.93

-13.51

0.001

 

P-within‡

 

0.001

0.001

    
 

Change 1–3

 

-4.63 ± 7.37

-1.9 ± 5.16

-2.81

-6.48

0.86

0.134

 

P-within‡

 

0.009

0.001

    
  1. P-within‡: The difference between time points and baseline (change values) in each treatment group. P†: The difference between the IVB group versus the PRP group